Global Liver Disease Treatment Market
According to the report“ Liver Disease Treatment Market ", published by Market Data Forecast, the global market is projected to reach USD 17.25 billion with a CAGR of 11.72 % from USD 9.25 billion in 2016.
Liver is a vital organ of the body performing umpteen complex functions such as fighting infections, removing toxins, bile secretion, and it produces clotting factors, proteins, and cholesterol, among others. Malfunctioning of liver can be life-threatening as it can cause multiple acute and chronic diseases( hepatitis, non-alcoholic fatty liver disease, liver cancer, liver tumour, and liver cirrhosis, among others). The initial symptoms of liver damage include nausea, fatigue, diarrhoea, jaundice, swollen abdomen, and mental disorientation among other. Acute liver damage can be treated through proper medication, if detected early, otherwise liver transplant is required. Liver damage can be prevented by adopting healthy lifestyle and practicing proper hygiene.
The growth of Liver Disease Treatment market is majorly driven by factors such as boost in Research & Development investment, unorganized lifestyle, rising public awareness, growth in geriatric population, and unmet needs for the treatment of liver cancer. Additionally, spur in demand for alcohol has increased the risk of liver cirrhosis. According to World Health Organization, alcohol consumption is anticipated to cause 20 % to 50 % of cirrhosis of the liver. Also, growing obese population has also increased the risk of non-alcoholic fatty liver disease which is caused by build-up of fat in the liver. The obese population has doubled since 1980. In 2014, approximately 13 % of the world’ s population, that is, more than 600 million adults were obese as per World Health Organization.
The global Liver Disease Treatment Market is segmented on the basis of Treatment Modality and Disease Type
Based on Treatment Modality
� � � � � �
Antiviral Vaccines Chemotherapy Immunosuppressive Agents Corticosteroids Others
Based on Disease Type
� � � � �
Hepatitis Non-Alcoholic Fatty Liver Disease Alcohol Induced Liver Cancer Others
Geographical Segmentation:
� �
North America Europe
+ 1 888-702-9626 | www. marketdataforecast. com | contact @ marketdataforecast. com